BECKMAN COULTER, INC.
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1935-01-01
- Employees
- 11.9K
- Market Cap
- -
Clinical Trials
30
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Adult MDW Dual Cut-Off Accuracy Study
- Conditions
- Sepsis
- First Posted Date
- 2025-03-20
- Last Posted Date
- 2025-03-20
- Lead Sponsor
- Beckman Coulter, Inc.
- Target Recruit Count
- 2225
- Registration Number
- NCT06885528
A Cut-off Value Study of N-terminal Brain Natriuretic Peptide （Chemiluminescence Method）
- Conditions
- Heart FailureAcute Coronary Syndromes
- First Posted Date
- 2024-11-15
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- Beckman Coulter, Inc.
- Target Recruit Count
- 1104
- Registration Number
- NCT06691477
- Locations
- 🇨🇳
Sun Yat-sen Memorial Hospital, Guangzhou, Guangzhou, China
🇨🇳Beckman Coulter, Shanghai, Shanghai, China
🇨🇳Beijing Anzhen Hospital, Capital Medical University, Beijing, China
Access BNP Clinical Enrollment Study
- Conditions
- Heart Failure
- First Posted Date
- 2024-10-02
- Last Posted Date
- 2025-04-23
- Lead Sponsor
- Beckman Coulter, Inc.
- Target Recruit Count
- 1100
- Registration Number
- NCT06624293
- Locations
- 🇺🇸
Loma Linda University Medical Center Department of Emergency Medicine, Loma Linda, California, United States
🇺🇸UC Davis Health Department of Emergency Medicine, Sacramento, California, United States
🇺🇸University of Florida College of Medicine, Gainesville, Florida, United States
Access MeMed BV Assay Clinical Study Collection Protocol - Infectious Adult and Pediatric Cohorts
- Conditions
- Infection ViralInfection, Bacterial
- First Posted Date
- 2024-04-23
- Last Posted Date
- 2025-06-05
- Lead Sponsor
- Beckman Coulter, Inc.
- Target Recruit Count
- 650
- Registration Number
- NCT06379061
- Locations
- 🇺🇸
Indiana University School of Medicine, Indianapolis, Indiana, United States
🇺🇸Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸Massachusetts General Brigham, Boston, Massachusetts, United States
Access Anti-HAV and Access Anti-HAV IgM Assays EU Clinical Trial Protocol (HAV-EU-11-23)
- Conditions
- HAV
- First Posted Date
- 2024-03-04
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Beckman Coulter, Inc.
- Target Recruit Count
- 1409
- Registration Number
- NCT06289868
- Locations
- 🇫🇷
Cerba Xpert, Frepillon, France
🇫🇷Eurofins Biomnis, Ivry-sur-Seine, France
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next